Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
  1. 4 Option exercise 10% owner acquired 1,000 shares (option exercise)
  2. 4 Option exercise 10% owner acquired 1,000 shares (option exercise)
  3. 4 Option exercise 10% owner acquired 1,000 shares (option exercise)
  4. 4 Open-market buy Director bought 6,000 shares at $5.09 ($30,534)
  5. 4/A Open-market buy President and CEO bought 20,000 shares at an average $4.43 ($88,577)
  6. 4 Open-market buy President and CEO bought 20,000 shares at an average $4.43 ($88,577)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4/A Open-market buy 10% owner bought 595,000 shares at $4.00 ($2,379,822)
  19. 4 Option exercise 10% owner acquired 3,333 shares (option exercise)
  20. 4 Option exercise 10% owner acquired 3,333 shares (option exercise)

Page 21 of 37 · 739 filings